CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 45 filers reported holding CONMED CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288,125 | -25.1% | 250,000 | 0.0% | 0.00% | – |
| Q2 2023 | $384,500 | -37.4% | 250,000 | -50.0% | 0.00% | – |
| Q1 2023 | $614,250 | +116.9% | 500,000 | +100.0% | 0.00% | – |
| Q4 2022 | $283,250 | +3.4% | 250,000 | 0.0% | 0.00% | – |
| Q3 2022 | $274,000 | -93.8% | 250,000 | -93.2% | 0.00% | – |
| Q2 2022 | $4,415,000 | -24.5% | 3,655,000 | +7.3% | 0.00% | – |
| Q1 2022 | $5,851,000 | +3.4% | 3,405,000 | 0.0% | 0.00% | – |
| Q4 2021 | $5,661,000 | +7.6% | 3,405,000 | 0.0% | 0.00% | – |
| Q3 2021 | $5,263,000 | -4.1% | 3,405,000 | 0.0% | 0.00% | – |
| Q2 2021 | $5,486,000 | +3.1% | 3,405,000 | 0.0% | 0.00% | – |
| Q1 2021 | $5,322,000 | +11.8% | 3,405,000 | 0.0% | 0.00% | – |
| Q4 2020 | $4,760,000 | +24.9% | 3,405,000 | 0.0% | 0.00% | – |
| Q3 2020 | $3,812,000 | +7.0% | 3,405,000 | 0.0% | 0.00% | – |
| Q2 2020 | $3,564,000 | -39.9% | 3,405,000 | -46.8% | 0.00% | -100.0% |
| Q1 2020 | $5,929,000 | – | 6,405,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mohican Financial Management, LLC | 3,000,000 | $4,690,000 | 3.05% |
| SHENKMAN CAPITAL MANAGEMENT INC | 10,045,000 | $15,854,000 | 1.85% |
| SSI INVESTMENT MANAGEMENT LLC | 8,408,000 | $13,144,000 | 0.95% |
| ZAZOVE ASSOCIATES LLC | 4,519,000 | $7,075,000 | 0.84% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 8,930,000 | $14,003,000 | 0.76% |
| III Capital Management | 3,750,000 | $5,876,000 | 0.70% |
| MACKAY SHIELDS LLC | 35,548,000 | $55,708,000 | 0.41% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,271,000 | $9,814,000 | 0.23% |
| Calamos Advisors LLC | 22,981,000 | $36,014,000 | 0.20% |
| Polar Asset Management Partners Inc. | 10,000,000 | $15,673,000 | 0.16% |